Clinical Trial

A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2016-04-06; most recent amendment 2025-04-08.
Status change: Recruiting → Active, Not Recruiting 2023-09-12
Status change: Active, Not Recruiting → Recruiting 2022-12-05
Status change: Enrolling by Invitation → Active, Not Recruiting 2021-07-07
Status change: Recruiting → Enrolling by Invitation 2017-12-13
Status change: Not Yet Recruiting → Recruiting 2016-11-15
Trial Details
NCT Number NCT02735083
Lead Sponsor Institut de Recherches Internationales Servier
Collaborators: ADIR, a Servier Group company
Conditions Advanced Lymphoid Leukemia
Enrollment 28 participants
Start Date 2021-03-10
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-11